# Horst Olschewski

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/horst-olschewski/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,458 |
| Field | Pulmonary Hypertension Research and Treatments |
| h-index | 95 |
| i10-index | 276 |
| Last Known Institution | Sigmund Freud Privatuniversität Wien |
| OpenAlex ID | https://openalex.org/A5077836810 |
| ORCID iD | https://orcid.org/0000-0002-2834-7466 |
| Works | 633 |

## Researcher papers

- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review](https://scholariq.org/papers/pulmonary-arterial-pressure-during-rest-and-exercise-in-healthy-subjects-a/)
- [Ambrisentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/ambrisentan-therapy-for-pulmonary-arterial-hypertension/)
- [Pulmonary vascular resistances during exercise in normal subjects: a systematic review](https://scholariq.org/papers/pulmonary-vascular-resistances-during-exercise-in-normal-subjects-a-systematic/)
- [Reading Pulmonary Vascular Pressure Tracings. How to Handle the Problems of Zero Leveling and Respiratory Swings](https://scholariq.org/papers/reading-pulmonary-vascular-pressure-tracings-how-to-handle-the-problems-of-zero/)
- [Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality](https://scholariq.org/papers/mild-elevation-of-pulmonary-arterial-pressure-as-a-predictor-of-mortality/)
- [ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension](https://scholariq.org/papers/ers-statement-on-exercise-training-and-rehabilitation-in-patients-with-severe/)
- [Zero reference level for right heart catheterisation](https://scholariq.org/papers/zero-reference-level-for-right-heart-catheterisation/)
- [Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial](https://scholariq.org/papers/switching-to-riociguat-versus-maintenance-therapy-with-phosphodiesterase-5/)

## Researcher topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Researcher university

- [Sigmund Freud Privatuniversität Wien](https://scholariq.org/institutions/sigmund-freud-privatuniversitat-wien/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.